gilupi.de
GILUPI - CellCollector in vivo CTC isolationThe GILUPI CellCollector is the first in vivo CTC isolation product worldwide which is CE approved
http://www.gilupi.de/
The GILUPI CellCollector is the first in vivo CTC isolation product worldwide which is CE approved
http://www.gilupi.de/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.4 seconds
16x16
32x32
64x64
128x128
160x160
192x192
256x256
PAGES IN
THIS WEBSITE
8
SSL
EXTERNAL LINKS
12
SITE IP
217.160.223.166
LOAD TIME
0.435 sec
SCORE
6.2
GILUPI - CellCollector in vivo CTC isolation | gilupi.de Reviews
https://gilupi.de
The GILUPI CellCollector is the first in vivo CTC isolation product worldwide which is CE approved
gilupi.de
GILUPI - über uns
http://www.gilupi.de/de/about.html
Die GILUPI GmbH ist ein Hersteller von Medizinprodukten mit Fokus auf Entwicklung und Produktion neuer innovativer Produkte zur. Ndash; Isolation von seltenen Zellen aus dem Blut. Unsere Produkte basieren dabei auf einer einzigartigen, patentierten Technologie. Gegenwärtig konzentrieren wir uns auf die Anwendung in Krebspatienten. Das erste zugelassene Medizinprodukt mit dieser neuen Technologie ist der GILUPI CellCollector. Ist das erste Produkt weltweit, das eine CE - Zertifizierung für die.
GILUPI - Neuigkeiten
http://www.gilupi.de/de/news.html
GILUPI GmbH Receives ISO 13485 Certification for Manufacturing and Distribution of Cell Separation Devices. GILUPI Strengthens Executive Team - Appoints Dr. Jens Pfannkuche as General Manager. GILUPI GmbH, a developer and manufacturer of medical devices to enrich circulating tumor cells (CTCs) in the human blood stream, announces that Dr. Jens Pfannkuche has been appointed to the position as General Manager of the GILUPI GmbH effective July 2016. The recently received patents are an important supplementa...
GILUPI - CellCollector
http://www.gilupi.de/de/cellcollector.html
Isolation von zirkulierenden Tumorzellen. Ist weltweit das erste CE-zertifizierte Produkt für die. Ndash; Isolation von zirkulierenden Tumorzellen. Bei mehr als 2200 Patienten wurde der GILUPI CellCollector. Bereits angewendet. In klinischen Studien in den Bereichen Lungen-, Prostata-, Brust-, und Darmkrebs konnten kontinuierlich CTCs nachgewiesen werden. Hierbei weist der GILUPI CellCollector. Anwendung des GILUPI CellCollector. Weltweit erste CE - Zulassung für die in vivo - Isolation von CTCs.
GILUPI - Impressum
http://www.gilupi.de/de/imprint.html
Haftung für Links. Fotolia.com, GILUPI.
GILUPI - CellCollector in vivo CTC isolation
http://www.gilupi.de/en/index.html
GILUPI offers healthcare solutions for personalized medicine. Our innovative medical devices, the GILUPI CellCollectors, enable the detection of rare cells directly from the blood of patients. The target cells (e.g. circulating tumor cells - CTCs in oncology) are obtained by. Cell isolation. The isolated cells can be characterized at the molecular level. This provides information to the doctors to treat their patients with individual therapies. In oncology, GILUPI’s CellCollector.
TOTAL PAGES IN THIS WEBSITE
8
Cancer Genomics | Alacris Theranostics GmbH
http://www.alacris.de/services/cancer-genomics
Cancer Genomics for Clinicians. Tumour and Disease Models. Tumour and Disease Models. Cancer Genomics for Clinicians. Identifying the right treatment for your patients the benefits of molecular profiling. Such comprehensive molecular profiling, now an affordable undertaking due to rapid progress in sequencing technologies, provides, in tandem with pathology data, a more accurate characterisation of individual tumours. In this way, so called actionable variants. Alacris Theranostics’ services:. Experiment...
GILUPI - about
http://www.gilupi.com/about.html
Who we are and what we do. GILUPI is a medical device company with focus on the development and production of new innovative products for the. Isolation of rare cells from the circulation. These products are based on a unique patented technology. Currently, the main focus of GILUPI is the diagnostics market for cancer. The first approved product with this new technology is the GILUPI CellCollector. Isolation of circulating tumor cells (CTCs). The GILUPI CellCollector.
GILUPI - downloads
http://www.gilupi.com/downloads.html
Instructions for Use – User Manual. Ndash; step by step. How to Wash and Fix. Ndash; step by step. Instructions for Use – User Manual Detektor CANCER 02. Ndash; step by step. How to Wash and Fix. Ndash; step by step. Application video Detektor CANCER02. German Cancer Congress 2016. ELCC European Lung Cancer Conference 2016. 29Treffpunkt Medizintechnik Berlin 2015 FOCCS. IASLC World Lung Cancer Conference 2015. Bdquo;22nd International Molecular Medicine Tri-Conference“ Lung Cancer. Poster 3rd European Lu...
GILUPI - imprint
http://www.gilupi.com/imprint.html
Pulver and Blei Die Werbeagentur. Fotolia.com, GILUPI.
Referenzen der SLM GmbH | speziallabor.com
http://www.speziallabor.com/referenzen
SLM – Speziallabor für angewandte. Fon 49 (0)30 . 63 92 38 85. Fax 49 (0)30 . 63 92 38 86. Weltweite Versorgung des Gesundheitsmarktes mit Produkten für Anästhesie, Intensivmedizin, Kardiologie und Chirurgie sowie mit Dienstleistungen für Ärzte, Kliniken und den Homecare- Bereich. BBMAG- Aesculap; BBMAG- Aesculap Chifa. Carl-Braun-Straße 1, 34212 Melsungen, www.bbraun.com. Spritzen und Kanülen in Spitzenqualität. Für Medizin und Veterinärmedizin. Schlesische Str. 26,. Das Unternehmen gehört zur Gruppe de...
Circulating tumor cell - Wikipedia, the free encyclopedia
https://en.wikipedia.org/wiki/Circulating_tumor_cell
From Wikipedia, the free encyclopedia. CTCs) are cells that have shed into the vasculature. From a primary tumor. And are carried around the body in the circulation. CTCs thus constitute seeds. For the subsequent growth of additional tumors ( metastases. In vital distant organs, triggering a mechanism that is responsible for the vast majority of cancer-related deaths. Modern cancer research has demonstrated that CTCs derive from clones in the primary tumor, validating Ashworth's remarks. Furthermore, hig...
GILUPI - CellCollector in vivo CTC isolation
http://www.gilupi.com/index.html
GILUPI offers healthcare solutions for personalized medicine. Our innovative medical devices, the GILUPI CellCollectors, enable the detection of rare cells directly from the blood of patients. The target cells (e.g. circulating tumor cells - CTCs in oncology) are obtained by. Cell isolation. The isolated cells can be characterized at the molecular level. This provides information to the doctors to treat their patients with individual therapies. In oncology, GILUPI’s CellCollector.
GILUPI - CellCollector
http://www.gilupi.com/cellcollector.html
Product worldwide which is CE approved. Has been deployed in more than 2200 patients, the results of lung, prostate, breast and colorectal cancer patients indicate consistent and high CTC detection rates and cell numbers (similar for early and late cancer stages). The GILUPI CellCollector. Has a high CTC detection rate of 70% in early and 72% in late cancer stages. How to use the GILUPI CellCollector. For more information, click here. CTC isolation CE approval worldwide. Proven safety and functionality.
GILUPI - Careers
http://www.gilupi.com/careers.html
Based on unique patented technology since its founding in 2006, GILUPI has developed new innovative products for the. Isolation of rare cells from circulating blood. Innovations, entrepreneurial thinking and highly motivated employees characterize the success of GILUPI. Would you like to join our team? Marketing and Clinical Project Management.
TOTAL LINKS TO THIS WEBSITE
12
Gilung.Org - Организация и поддержка любых мероприятий
Организация и поддержка любых мероприятий. A part of Gilung.Biz.
Home :: GIL University
What is GIL University. Mega Trend Think Tank. A unique life-changing 12-month experiential program founded on cutting-edge research and industry best practices delivered by renowned practising leaders. August 2014 - Iskandar, Malaysia. Aimed at senior executives, these innovative workshops can be attended as standalone interactive modules or a series of interconnected learning units. Mega Trend Think Tank. Founded on best practice thinking, these interactive workshops help individuals accelerate their c...
簡単でお店のチャーハン風にする方法。
gilunyjeremipotter.skyrock.com
GilunyJeremiPotter's blog - GJP - Skyrock.com
More options ▼. Subscribe to my blog. Tourner la page (contagieuse). Created: 16/11/2012 at 10:09 AM. Updated: 27/01/2016 at 12:43 AM. You are not a VIP! To see their 2 secret articles, log in! Coucou mes p'tits Potterheads 3! Alors voilà, j'écris en ce moment une nouvelle fanfiction mais arrivée au chapitre 8 je suis à cours d'inspiration, je vais donc faire la liste de mes fanfictions préférées (Harry Potter ou autres). Je modiefierai cet article au fur et à mesure. Voilà! 65279;Nous avions gardé espoir.
GILUPI - CellCollector in vivo CTC isolation
GILUPI offers healthcare solutions for personalized medicine. Our innovative medical devices, the GILUPI CellCollectors, enable the detection of rare cells directly from the blood of patients. The target cells (e.g. circulating tumor cells - CTCs in oncology) are obtained by. Cell isolation. The isolated cells can be characterized at the molecular level. This provides information to the doctors to treat their patients with individual therapies. In oncology, GILUPI’s CellCollector.
GILUPI - CellCollector in vivo CTC isolation
Die GILUPI GmbH bietet Gesundheitslösungen für die personalisierte Medizin. Unser innovatives Medizinprodukt, der GILUPI CellCollector. Ermöglicht die Detektion seltener Zellen aus dem Blut von Patienten. Die Zielzellen, zum Beispiel zirkulierende Tumorzellen (engl. circulating tumor cells - CTCs) in der Onkologie, werden.
Test Page for 000000000000.it
Welcome in MondoServer.it. This is the default page for MondoServer IT on this server.
www.gilur.net
Please enter password to access this page. Please enter password to access this page. Powered by Password Protect.
Ana Mar Gil Urnicia
